How to buy Sanofi stock | $52.43

Sanofi is a drug manufacturers-general business based in the US. Sanofi shares (SNY) are listed on the NASDAQ and all prices are listed in US Dollars. Sanofi employs 99,412 staff and has a trailing 12-month revenue of around 0.00.

Sanofi stock price (NASDAQ: SNY)

Use our graph to track the performance of SNY stocks over time.

Sanofi shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$52.43
52-week range	$43.13 - $54.26
50-day moving average	$52.36
200-day moving average	$50.42
Wall St. target price	$65.00
PE ratio	9.1357
Dividend yield	$3.2 (6.2%)
Earnings per share (TTM)	$5.70

Buy Sanofi shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Sanofi stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Sanofi by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sanofi price performance over time

Historical closes compared with the close of $52.43 from 2021-06-04

1 week (2021-07-25)	N/A
1 month (2021-07-02)	0.11%
3 months (2021-05-05)	3.66%
6 months (2021-02-01)	N/A

1 year (2020-08-01)	N/A
2 years (2019-08-01)	N/A
3 years (2018-08-01)	N/A
5 years (2016-08-01)	N/A

Is Sanofi under- or over-valued?

Valuing Sanofi stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sanofi's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Sanofi's P/E ratio

Sanofi's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Sanofi shares trade at around 9x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Sanofi's PEG ratio

Sanofi's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.1176. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Sanofi's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Sanofi's EBITDA

Sanofi's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10.6 billion.

The EBITDA is a measure of a Sanofi's overall financial performance and is widely used to measure a its profitability.

Sanofi financials

Revenue TTM	$36.9 billion
Operating margin TTM	21.1%
Gross profit TTM	$25.3 billion
Return on assets TTM	4.19%
Return on equity TTM	20.01%
Profit margin	33.02%
Book value	$25.19
Market capitalisation	$130.4 billion

TTM: trailing 12 months

Shorting Sanofi shares

There are currently 3.9 million Sanofi shares held short by investors – that's known as Sanofi's "short interest". This figure is 20.8% down from 5.0 million last month.

There are a few different ways that this level of interest in shorting Sanofi shares can be evaluated.

Sanofi's "short interest ratio" (SIR)

Sanofi's "short interest ratio" (SIR) is the quantity of Sanofi shares currently shorted divided by the average quantity of Sanofi shares traded daily (recently around 1.5 million). Sanofi's SIR currently stands at 2.54. In other words for every 100,000 Sanofi shares traded daily on the market, roughly 2540 shares are currently held short.

However Sanofi's short interest can also be evaluated against the total number of Sanofi shares, or, against the total number of tradable Sanofi shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sanofi's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Sanofi shares in existence, roughly 0 shares are currently held short) or 0.0018% of the tradable shares (for every 100,000 tradable Sanofi shares, roughly 2 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Sanofi.

Find out more about how you can short Sanofi stock.

Sanofi share dividends

Dividend payout ratio: 53.97% of net profits

Recently Sanofi has paid out, on average, around 53.97% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.74% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Sanofi shareholders could enjoy a 3.74% return on their shares, in the form of dividend payments. In Sanofi's case, that would currently equate to about $3.2 per share.

Sanofi's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

Sanofi's most recent dividend payout was on 25 May 2021. The latest dividend was paid out to all shareholders who bought their shares by 2 May 2021 (the "ex-dividend date").

Have Sanofi's shares ever split?

Sanofi's shares were split on a 5:1 basis on 29 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Sanofi shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Sanofi shares which in turn could have impacted Sanofi's share price.

Sanofi share price volatility

Over the last 12 months, Sanofi's shares have ranged in value from as little as $43.131 up to $54.26. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sanofi's is 0.4028. This would suggest that Sanofi's shares are less volatile than average (for this exchange).

Sanofi overview

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange.

Frequently asked questions

What percentage of Sanofi is owned by insiders or institutions?
Currently 0.001% of Sanofi shares are held by insiders and 8.005% by institutions. How many people work for Sanofi?
Latest data suggests 99,412 work at Sanofi. When does the fiscal year end for Sanofi?
Sanofi's fiscal year ends in December. Where is Sanofi based?
Sanofi's address is: 54, Rue La BoEtie, Paris, France, 75008 What is Sanofi's ISIN number?
Sanofi's international securities identification number is: US80105N1054 What is Sanofi's CUSIP number?
Sanofi's Committee on Uniform Securities Identification Procedures number is: 053561106